Article L232-10-3
…bidden for any person to aid or abet, or attempt to aid or abet, a violation of the anti-doping rules.
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 2451–2460 of 66871 articles for “Art. s. 1591 and 1592 · Cass. com. 3 May 1977”
…bidden for any person to aid or abet, or attempt to aid or abet, a violation of the anti-doping rules.
In the context of the investigations mentioned in articles L. 232-5 and L. 232-18-1, professional secrecy may not be invoked against the French Anti-Doping Agency and its investigators or, where appli…
…e laboratory used by the Agency for the analysis of the Samples shall give it access to the Samples and related information so that it can make use of them.
The declaration provided for in Article L. 123-29 is sent by registered letter with acknowledgement of receipt or delivered against receipt.If the application is incomplete, the regional chamber of co…
…rd allowing the exercise of an itinerant commercial or craft activity, provided for in article L. 123-29, is signed by the president of the consular chamber or his representative. It includes the foll…
…ng authorisation holder must immediately forward to the National Agency for the Safety of Medicines and Health Products, indicating the scope of the information, any new data which it has or becomes a…
The Director General of the Agence nationale de sécurité du médicament et des produits de santé may require samples and mock-ups to be submitted when the medicinal product is marketed.
…product, previously marketed on national territory, is no longer marketed for three consecutive years. A derogation from these provisions may be granted by the Agency on an exceptional basis, either f…
The marketing authorisation may impose one or more of the following conditions, which must be mentioned in the risk management system: 1° The implementation of measures to ensure the safe use of the m…
…12, the Director General of the Agence nationale de sécurité du médicament et des produits de santé may, by reasoned decision notified in writing, where he has concerns about the risks associated with…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More